机构:[1]Department of Urology, Tangshan Gongren Hospital, Tangshan, China[2]Department of Pathology, The Hospital of Heilongjiang Province, Harbin, China[3]Department of Internal Medicine, The Tumor Hospital of Qingdao City, Qingdao, China[4]Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室肾脏内科昆明医科大学附属第一医院
OBJECTIVE: To investigate the effects of miR-519d on the proliferation, cycle and invasion of human prostate cancer PC3 cells and its possible molecular mechanism. MATERIALS AND METHODS: The proliferation, cycle, and invasion of human prostate cancer PC3 cells were detected via cell counting kit-8 (CCK-8) and transwell assay. The expression of NRBP1 mRNA was detected via reverse transcription-polymerase chain reaction (RT-PCR). Western blotting was used to detect the expression of NRBP1, cyclin D1, and epithelial-mesenchymal transition (EMT) markers. RESULTS: The expression of miR-519d in prostate cancer was decreased, which was correlated with tumor size, metastasis, and staging. Proliferation, cycle, and invasion of PC3 cells were significantly decreased after overexpression of miR-519d. Bioinformatics analysis and Western blotting showed that there was a potential miR-519d binding site in NRBP1 3'-UTR, and overexpression of miR-519d significantly inhibited the expression of NRBP1. The expression of E-cadherin in PC3 cells overexpressing miR-519d was up-regulated, and the expressions of N-cadherin, cyclin D1, vimentin, fibronectin, and Snail were down-regulated. CONCLUSIONS: MiR-519d can repress the proliferation, cycle, and invasion of prostate cancer PC3 cells by inhibiting NRBP1.
第一作者机构:[1]Department of Urology, Tangshan Gongren Hospital, Tangshan, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yan C. -Q.,Lu Y. -H.,Tang S. -M.,et al.MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1[J].EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES.2018,22(10):2985-2990.
APA:
Yan, C. -Q.,Lu, Y. -H.,Tang, S. -M.&Fan, W. -X..(2018).MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,22,(10)
MLA:
Yan, C. -Q.,et al."MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 22..10(2018):2985-2990